Germany
Japan
United Kingdom
China
Antibodies
View as table Download
HTR6 / 5-HT6 Rabbit Polyclonal (C-Terminus) Antibody
| Applications | IHC |
| Reactivities | Gibbon, Chimpanzee, Dog, Gorilla, Hamster, Horse, Human, Monkey, Rat |
| Conjugation | Unconjugated |
WNT7A Rabbit Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Bat, Bovine, Chimpanzee, Chicken, Guinea Pig, Hamster, Human, Monkey, Mouse, Orang-Utan, Rabbit, Rat, Xenopus, Gorilla, Dog, Pig, Horse, Gibbon |
| Conjugation | Unconjugated |
Dopamine Receptor D3 / DRD3 Rabbit Polyclonal (Cytoplasmic Domain) Antibody
| Applications | IHC |
| Reactivities | Bat, Gibbon, Chimpanzee, Dog, Hamster, Horse, Human, Monkey, Mouse, Pig |
| Conjugation | Unconjugated |
NR2E3 / PNR Rabbit Polyclonal (Ligand-binding Domain) Antibody
| Applications | IHC |
| Reactivities | Bat, Gibbon, Bovine, Chimpanzee, Gorilla, Hamster, Horse, Human, Mouse, Pig |
| Conjugation | Unconjugated |
TAAR1 Rabbit Polyclonal (Cytoplasmic Domain) Antibody
| Applications | IHC |
| Reactivities | Chimpanzee, Human, Monkey |
| Conjugation | Unconjugated |
Mouse monoclonal anti-LGR4 antibody
| Applications | IHC |
| Reactivities | Chimpanzee, Human, Macaque |
| Conjugation | Unconjugated |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | ELISA, FC, IHC |
| Reactivities | Chimpanzee, Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | ELISA, FC, IHC |
| Reactivities | Chimpanzee, Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | ELISA, FC, IHC |
| Reactivities | Chimpanzee, Human |
| Conjugation | Unconjugated |
| Modifications | NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-CD81 (Clone 1D6)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Chimpanzee, Goat, Human, Sheep |
| Conjugation | Unconjugated |
Recombinant Anti-CD81 (Clone 1D6)
| Applications | ELISA, FC, IF, IHC, IP, WB |
| Reactivities | Chimpanzee, Goat, Human, Sheep |
| Conjugation | Unconjugated |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. |
Recombinant Anti-Fc gamma receptor III (Clone 3G8)
| Applications | FC, IHC, IP |
| Reactivities | Chimpanzee, Human, Macaque, Marmoset, Monkey, Baboon, Cynomolgus |
| Conjugation | Unconjugated |
Active filters
Filter by
Target Symbol
- CD4 (3)
- CD16 (2)
- CD81 (2)
- DRD2 (2)
- DRD3 (2)
- GBA (2)
- GLG1 (2)
- OLFM4 (2)
- SLC7A2 (2)
- TPP1 (2)
- TUBA1A (2)
- ACTB (1)
- ADRB2 (1)
- AHSA1 (1)
- APEX1 (1)
- APP (1)
- ASAP1 (1)
- ATRX (1)
- CAMK4 (1)
- CAP1 (1)
- CCT2 (1)
- CD74 (1)
- CENPU (1)
- CMTM6 (1)
- COX4I1 (1)
- E2F1 (1)
- EGR1 (1)
- ENO1 (1)
- ENTPD2 (1)
- FAM3C (1)
- FANCG (1)
- FIG4 (1)
- FMO2 (1)
- GAD1 (1)
- GLI3 (1)
- GLUD1 (1)
- GOT1 (1)
- GPX2 (1)
- GPX7 (1)
- HNRNPC (1)
- HNRNPF (1)
- HRH1 (1)
- HRH2 (1)
- HTR6 (1)
- KIAA1324 (1)
- KLRC1 (1)
- LDB2 (1)
- LGR4 (1)
- LMNA (1)
- MC1R (1)
- MPP6 (1)
- MRGPRX2 (1)
- MTSS1 (1)
- NAPA (1)
- NDUFA12 (1)
- NDUFA5 (1)
- NDUFAB1 (1)
- NDUFB5 (1)
- NDUFS1 (1)
- NDUFS2 (1)
- NDUFS8 (1)
- NDUFV1 (1)
- NDUFV2 (1)
- NOTCH2 (1)
- NOXO1 (1)
- NR2E3 (1)
- P4HB (1)
- PDHA1 (1)
- PGR (1)
- PSMA6 (1)
- RAB2A (1)
- SEPHS1 (1)
- SERPINA7 (1)
- SLC11A2 (1)
- SLC39A14 (1)
- SLC44A2 (1)
- SLC4A2 (1)
- SLC5A9 (1)
- SPRY4 (1)
- STAT2 (1)
- TAAR1 (1)
- TM9SF3 (1)
- TMEM59 (1)
- TPI1 (1)
- TRPC6 (1)
- TSPAN13 (1)
- TUBA1B (1)
- WNT7A (1)
- YIPF4 (1)
Antibody Hosts
Clonalities
Conjugates
Modifications
- Phospho-specific (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Families
- Druggable Genome (56)
- Transmembrane (37)
- GPCR (12)
- Transcription Factors (7)
- Secreted Protein (4)
- Stem cell - Pluripotency (4)
- Protease (3)
- ES Cell Differentiation/IPS (2)
- Nuclear Hormone Receptor (2)
- Adult stem cells (1)
- Cancer stem cells (1)
- Embryonic stem cells (1)
- Ion Channels: Transient receptor potential (1)
Pathways
- Metabolic pathways (18)
- Alzheimer's disease (10)
- Neuroactive ligand-receptor interaction (10)
- Huntington's disease (9)
- Oxidative phosphorylation (9)
- Parkinson's disease (9)
- Gap junction (5)
- Lysosome (5)
- Calcium signaling pathway (4)
- Pathogenic Escherichia coli infection (4)
- Alanine (3)
- Glycolysis / Gluconeogenesis (3)
- Pathways in cancer (3)
- aspartate and glutamate metabolism (3)
- Antigen processing and presentation (2)
- Arachidonic acid metabolism (2)
- Arginine and proline metabolism (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Basal cell carcinoma (2)
- Butanoate metabolism (2)
- Cell adhesion molecules (CAMs) (2)
- Dilated cardiomyopathy (2)
- Glutathione metabolism (2)
- Hedgehog signaling pathway (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Jak-STAT signaling pathway (2)
- Melanogenesis (2)
- Other glycan degradation (2)
- Sphingolipid metabolism (2)
- Adherens junction (1)
- Base excision repair (1)
- Bladder cancer (1)
- Cardiac muscle contraction (1)
- Cell cycle (1)
- Chemokine signaling pathway (1)
- Chronic myeloid leukemia (1)
- Citrate cycle (TCA cycle) (1)
- Cysteine and methionine metabolism (1)
- D-Glutamine and D-glutamate metabolism (1)
- Dorso-ventral axis formation (1)
- Drug metabolism - cytochrome P450 (1)
- Endocytosis (1)
- Focal adhesion (1)
- Fructose and mannose metabolism (1)
- Glioma (1)
- Graft-versus-host disease (1)
- Inositol phosphate metabolism (1)
- Leukocyte transendothelial migration (1)
- Melanoma (1)
- Natural killer cell mediated cytotoxicity (1)
- Nitrogen metabolism (1)
- Non-small cell lung cancer (1)
- Notch signaling pathway (1)
- Oocyte meiosis (1)
- Pancreatic cancer (1)
- Phenylalanine (1)
- Phenylalanine metabolism (1)
- Prion diseases (1)
- Progesterone-mediated oocyte maturation (1)
- Prostate cancer (1)
- Proteasome (1)
- Purine metabolism (1)
- Pyruvate metabolism (1)
- RNA degradation (1)
- Regulation of actin cytoskeleton (1)
- Selenoamino acid metabolism (1)
- Small cell lung cancer (1)
- Spliceosome (1)
- Taurine and hypotaurine metabolism (1)
- Tight junction (1)
- Type I diabetes mellitus (1)
- Tyrosine metabolism (1)
- Valine (1)
- Vibrio cholerae infection (1)
- Viral myocarditis (1)
- Wnt signaling pathway (1)
- beta-Alanine metabolism (1)
- leucine and isoleucine biosynthesis (1)
- tyrosine and tryptophan biosynthesis (1)